Total planned funding: $332,699,553
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $97,960,358 |
Mozambique | $48,781,184 |
Kenya | $45,207,118 |
Zambia | $24,616,891 |
Vietnam | $11,735,444 |
Ethiopia | $11,469,000 |
Tanzania | $11,081,695 |
Botswana | $9,739,397 |
South Africa | $8,561,687 |
Burundi | $8,390,534 |
Rwanda | $7,952,319 |
Côte d'Ivoire | $7,428,330 |
Indonesia | $5,026,155 |
Guyana | $4,670,000 |
Uganda | $3,868,804 |
India | $3,723,000 |
Asia Regional Program | $3,654,954 |
Papua New Guinea | $3,189,171 |
Democratic Republic of the Congo | $3,140,000 |
Caribbean Region | $2,717,206 |
Malawi | $2,210,000 |
Central America Region | $1,646,143 |
Haiti | $1,560,713 |
Angola | $1,085,000 |
South Sudan | $1,051,916 |
Cameroon | $700,000 |
Eswatini | $513,737 |
Dominican Republic | $500,000 |
Central Asia Region | $300,000 |
Namibia | $218,797 |
Ghana | $0 |
Lesotho | $0 |
Organizational Types
NGO | $332,699,553 |
Program Areas
Treatment | $102,450,842 |
Care | $92,116,127 |
Prevention | $90,536,548 |
Testing | $25,765,490 |
Governance and Systems | $21,830,546 |
Budget Codes
HTXS: Treatment: Adult Treatment | $83,276,995 |
HBHC: Care: Adult Care and Support | $48,562,154 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $39,185,868 |
HVOP: Sexual Prevention: Other Sexual Prevention | $31,561,687 |
HKID: Care: Orphans and Vulnerable Children | $27,964,014 |
HVCT: Testing: HIV Testing and Counseling | $25,765,490 |
HTXD: Treatment: ARV Drugs | $15,840,370 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,673,182 |
HVTB: Care: TB/HIV | $10,494,524 |
HLAB: Laboratory Infrastructure | $7,912,681 |
HVSI: Strategic Information | $7,546,117 |
OHSS: Health Systems Strengthening | $6,371,748 |
PDCS: Care: Pediatric Care and Support | $5,095,435 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $4,936,093 |
PDTX: Treatment: Pediatric Treatment | $3,333,477 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,719,279 |
HMIN: Biomedical Prevention: Injection Safety | $388,291 |
HMBL: Biomedical Prevention: Blood Safety | $72,148 |